Keros Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/12/2025 | 3.95 M | $94.53 M | 100.00% | 9.73% | |
BLACKROCK, INC. | 05/02/2025 | 2.79 M | $28.38 M | 2.05% | 6.87% |
JPMORGAN CHASE & CO | 05/12/2025 | 2.60 M | $26.50 M | 1,118.41% | 6.41% |
VANGUARD GROUP INC | 05/09/2025 | 2.57 M | $26.15 M | 31.13% | 6.33% |
MORGAN STANLEY | 05/15/2025 | 1.70 M | $17.30 M | 158.46% | 4.19% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.51 M | $15.35 M | 64.67% | 3.72% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.49 M | $15.15 M | 6,294.48% | 3.66% |
STATE STREET CORP | 05/15/2025 | 1.30 M | $13.27 M | 8.24% | 3.21% |
D. E. SHAW & CO., INC. | 05/15/2025 | 1.26 M | $12.87 M | 10,339.95% | 3.11% |
FEDERATED HERMES, INC. | 05/08/2025 | 1.22 M | $12.47 M | 882.30% | 3.02% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.10 M | $11.21 M | 100.00% | 2.71% |
ORBIMED ADVISORS LLC | 05/15/2025 | 1.02 M | $10.38 M | 0.00% | 2.51% |
ALKEON CAPITAL MANAGEMENT LLC | 05/15/2025 | 850.51 K | $8.67 M | -22.75% | 2.10% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 806.19 K | $8.22 M | 5.32% | 1.99% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 740.61 K | $7.55 M | 38.28% | 1.83% |
REDMILE GROUP, LLC | 05/15/2025 | 552.51 K | $5.63 M | 0.00% | 1.36% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 473.10 K | $4.82 M | 926.25% | 1.17% |
DRW SECURITIES, LLC | 05/15/2025 | 464.90 K | $4.74 M | 100.00% | 1.15% |
FMR LLC | 05/12/2025 | 441.54 K | $4.50 M | -92.03% | 1.09% |
05/14/2025 | 408.23 K | $4.16 M | 100.00% | 1.01% | |
CAPTION MANAGEMENT, LLC | 05/15/2025 | 392.90 K | $4.00 M | 100.00% | 0.97% |
05/15/2025 | 389.38 K | $3.97 M | -4.40% | 0.96% | |
NORTHERN TRUST CORP | 05/13/2025 | 290.01 K | $2.96 M | -2.18% | 0.72% |
PDT PARTNERS, LLC | 05/15/2025 | 276.06 K | $2.81 M | 100.00% | 0.68% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 274.01 K | $2.79 M | 100.00% | 0.68% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 273.34 K | $2.79 M | 100.00% | 0.67% |
BLUE OWL CAPITAL HOLDINGS LP | 05/15/2025 | 266.03 K | $2.71 M | 9.64% | 0.66% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 250.00 K | $2.55 M | 0.00% | 0.62% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 241.92 K | $2.47 M | -13.50% | 0.60% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 233.20 K | $2.38 M | -73.44% | 0.58% |
PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2025 | 217.75 K | $2.22 M | -30.77% | 0.54% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 202.30 K | $2.06 M | 896.55% | 0.50% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 05/15/2025 | 198.41 K | $2.02 M | 16,297.60% | 0.49% |
CITADEL ADVISORS LLC | 05/15/2025 | 191.61 K | $1.95 M | -75.78% | 0.47% |
TFG ASSET MANAGEMENT GP LTD | 05/15/2025 | 183.00 K | $1.86 M | 77.67% | 0.45% |
22NW, LP | 05/14/2025 | 179.00 K | $1.82 M | 100.00% | 0.44% |
RBF CAPITAL, LLC | 05/15/2025 | 170.01 K | $1.73 M | 100.00% | 0.42% |
CITADEL ADVISORS LLC | 05/15/2025 | 165.10 K | $1.68 M | 1,079.29% | 0.41% |
CLEARBRIDGE INVESTMENTS, LLC | 05/13/2025 | 156.72 K | $1.60 M | -17.54% | 0.39% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 155.61 K | $1.59 M | -3.63% | 0.38% |
WALLEYE CAPITAL LLC | 05/14/2025 | 150.50 K | $1.53 M | -23.86% | 0.37% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 147.57 K | $1.50 M | 100.00% | 0.36% |
05/15/2025 | 147.10 K | $1.50 M | 13.15% | 0.36% | |
CITADEL ADVISORS LLC | 05/15/2025 | 138.70 K | $1.41 M | 118.43% | 0.34% |
JANE STREET GROUP, LLC | 05/19/2025 | 136.40 K | $1.39 M | -73.23% | 0.34% |
WESTERN STANDARD LLC | 05/15/2025 | 134.91 K | $1.37 M | 100.00% | 0.33% |
DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 130.32 K | $1.33 M | 0.00% | 0.32% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/12/2025 | 128.10 K | $1.31 M | 339.52% | 0.32% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 121.85 K | $1.24 M | -42.34% | 0.30% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 119.50 K | $1.22 M | 477.29% | 0.29% |
Keros Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 199 institutional investors and hedge funds held shares of Keros Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 2.79 M
JPMORGAN CHASE & CO: 2.6 M
VANGUARD GROUP INC: 2.57 M
MORGAN STANLEY: 1.7 M
Nantahala Capital Management, LLC: 1.51 M
ADAR1 Capital Management, LLC: 1.49 M
85.15% of Keros Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 32.79 M shares in the last 24 months. This purchase volume represents approximately $441.01 M in transactions.